Valuation · US stocks
DexCom, Inc. (DXCM) valuation
As of 2026-11-18, DexCom, Inc. trades at $82.52, inside its 1-year fair-value range.
- Price
- $82.52
- Day change
- +0.59%
- Market cap
- $31.90B
- Sector
- Medical Specialties
- Valuation
- Fair
- As of
- 2026-11-18
Options
Options price a move of ±4.70% to the 2026-11-20 expiry (implied volatility 42.36%). DXCM gamma exposure
Other Medical Specialties stocks
| Stock | Price | Market cap | Valuation |
|---|---|---|---|
| Thermo Fisher Scientific Inc. TMO | $692.83 | $222.97B | High |
| Abbott Laboratories ABT | $104.49 | $182.68B | High |
| Intuitive Surgical, Inc. ISRG | $420.95 | $157.52B | Above band |
| Danaher Corporation DHR | $228.46 | $140.58B | Fair |
| Medtronic Plc MDT | $100.69 | $118.45B | Fair |
| Stryker Corporation SYK | $318.12 | $106.03B | Below band |
| Boston Scientific Corporation BSX | $43.66 | $63.59B | Low |
| Edwards Lifesciences Corporation EW | $105.19 | $60.21B | Above band |
| Becton, Dickinson and Company BDX | $216.04 | $57.71B | Fair |
| IDEXX Laboratories, Inc. IDXX | $698.47 | $53.01B | Fair |
| Medline, Inc. Class A MDLN | $39.16 | $52.17B | Above band |
| Agilent Technologies, Inc. A | $177.27 | $40.27B | Fair |
How the valuation band works
Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.